The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Src family kinases in tumor progression and metastasis
Abstract
The Src family of non-receptor protein tyrosine kinases plays critical roles in a variety of cellular signal transduction pathways, regulating such diverse processes as cell division, motility, adhesion, angiogenesis, and survival. Constitutively activated variants of Src family kinases, including the viral oncoproteins v-Src and v-Yes, are capable of inducing malignant transformation of a variety of cell types. Src family kinases, most notably although not exclusively c-Src, are frequently overexpressed and/or aberrantly activated in a variety of epithelial and non-epithelial cancers. Activation is very common in colorectal and breast cancers, and somewhat less frequent in melanomas, ovarian cancer, gastric cancer, head and neck cancers, pancreatic cancer, lung cancer, brain cancers, and blood cancers. Further, the extent of increased Src family activity often correlates with malignant potential and patient survival. Activation of Src family kinases in human cancers may occur through a variety of mechanisms and is frequently a critical event in tumor progression. Exactly how Src family kinases contribute to individual tumors remains to be defined completely, however they appear to be important for multiple aspects of tumor progression, including proliferation, disruption of cell/cell contacts, migration, invasiveness, resistance to apoptosis, and angiogenesis. This review details the evidence for Src family activation in human tumors, and emphasizes possible consequences to tumor progression. Given the ability of Src and its family members to participate in so many aspects of tumor progression and metastasis, Src family kinases are attractive targets for future anti-cancer therapeutics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“SRC kinase, a cytoplasmic non-receptor tyrosine kinase, has been implicated in the development and progression of cancer [19–22].”
From Co-targeting SRC overcomes resistance to BRAF inhibitors in colorectal cancer (2025) · cites this paper as [22]
In the citing paper
“In addition to MAPK, SRC kinases can directly modulate many downstream targets including and c-MYC [19, 21, 22, 44], related to drug resistance and tumor cell survival.”
From Co-targeting SRC overcomes resistance to BRAF inhibitors in colorectal cancer (2025) · cites this paper as [22]
Citations
Cites
CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASES
Thomas, S. Μ., & Brugge, J. S. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.513 · Cited by 2,537
Transforming gene product of Rous sarcoma virus phosphorylates tyrosine
Hunter, T. R., & Sefton, B. M. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1311 · Cited by 2,333
Three-dimensional structure of the tyrosine kinase c-Src
Xu, W., Harrison, S. C., & Eck, M. J. (1997) · Nature · doi:10.1038/385595a0 · Cited by 1,432
DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA
STEHELIN, D., VARMUS, H. E., BISHOP, J. M., & VOGT, P. K. (1976) · Nature · doi:10.1038/260170a0 · Cited by 1,321 · cited 2×
“Through then very tedious molecular approaches, Bishop and Varmus [3] demonstrated that the viral Src gene (v-src) had as its progenitor a normal cellular gene (proto-oncogene) c-src, an experiment largely responsible for the awarding of the”
BackgroundRegulation, substrates and functions of src
Brown, M. T., & Cooper, J. A. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00003-0 · Cited by 1,193
Crystal structure of the Src family tyrosine kinase Hck
Sicheri, F., Moarefi, I., & Kuriyan, J. (1997) · Nature · doi:10.1038/385602a0 · Cited by 1,171
A SARCOMA OF THE FOWL TRANSMISSIBLE BY AN AGENT SEPARABLE FROM THE TUMOR CELLS
Rous, P. (1911) · Journal of Experimental Medicine · doi:10.1084/jem.13.4.397 · Cited by 1,051
Tyrosine kinase/p21ras/MAP‐kinase pathway activation by estradiol‐receptor complex in MCF‐7 cells.
Migliaccio, A., Domenico, M. D., Castoria, G., de Falco, A., Bontempo, P., Nola, E., & Auricchio, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00471.x · Cited by 950
Identification of a transformation-specific antigen induced by an avian sarcoma virus
Brugge, J. S., & Erikson, R. L. (1977) · Nature · doi:10.1038/269346a0 · Cited by 889
Role of Src expression and activation in human cancer
Irby, R., & Yeatman, T. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203912 · Cited by 878
Cited by
Items 801–845 of 845
Cicero, J., Trouvilliez, S., Palma, M., Ternier, G., Decoster, L., Happernegg, E., Barois, N., Outryve, A. V., Dehouck, L., Bourette, R. P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26651691
Gong, L., Chen, Z., Feng, K., Luo, L., Zhang, J., Yuan, J., Ren, Y., Wang, Y., Zheng, X., & Li, Q. (2024) · Figshare · doi:10.6084/m9.figshare.25389425
Slap restricts oncogenic Src-family kinase signaling to maintain colonic epithelial homeostasis
Naim, D., HOUHOU, Z., Cauchois, F., Espie, K., Simon, V., Boublik, Y., Vives, F. L., Homayed, Z., Paul, C., Maillard, M., et al. (2026) · eLife · doi:10.64898/2026.01.05.697659
Upregulation of EphA2 by Src counteracts Src-induced loss of cell adhesion.
Takada, M., Murata, M., Soeda, S., Honda, T., Yuki, R., & Nakayama, Y. (2026) · Experimental Cell Research · doi:10.1016/j.yexcr.2026.114898
Signalisation oncogénique des tyrosine kinases et thérapies ciblées dans le cancer colorectal
Leroy, C. (2010) · theses.fr (ABES) · doi:10.70675/2ed0fd50z4cdfz44fazb610ze1e6911d3e30
Régulation de l'invasion cellulaire induite par les tyrosine kinases dans le cancer du sein
Chevalier, C. (2014) · theses.fr (ABES) · doi:10.70675/692c8de1za82az4e5ez953bz5e90670eb75d
Slap restricts oncogenic Src-family kinase signaling to maintain colonic epithelial homeostasisPreprint
Naim, D., HOUHOU, Z., Cauchois, F., Simon, V., Vives, F. L., Homayed, Z., Paul, C., Hahne, M., Pannequin, J., Nguyen, J., et al. (2026) · eLife · doi:10.7554/elife.110324.1
Rôle des complexes WASH et exocyste dans l’invasion tumorale
Monteiro, P. (2014) · theses.fr (ABES) · doi:10.70675/bc648be3z6f56z4ef5z9dd9z091f3adfc4bc
Mercier, M.-C. (2018) · theses.fr (ABES) · doi:10.70675/273bcce1z8572z472ez9afbzca3fd562301c
QSAR Study for Developing a New c-SRC Tyrosine Kinase Inhibitors
Naanaa, M., Sliman, F., & Barakat, H. (2026) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2026.00295
Embaby, D., El-Rashedy, A. A. E., Hammad, S. F., & Elshaier, Y. A. M. M. (2026) · ChemistrySelect · doi:10.1002/slct.202506991
Jeong, J.-H., Park, H.-J., Chi, G., Choi, Y.-H., & Park, S. (2026) · Nutrition and Cancer · doi:10.1080/01635581.2026.2698769
Hao, M., Fu, Y., Lin, Y., Wang, Y., Li, L., Fu, D., Yao, B., Fu, J., Zhou, Z., Su, J., et al. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.154389
Slap restricts oncogenic Src-family kinase signaling to maintain colonic epithelial homeostasisPreprint
Naim, D., HOUHOU, Z., Cauchois, F., Espie, K., Simon, V., Boublik, Y., Vives, F. L., Homayed, Z., Paul, C., Maillard, M., et al. (2026) · eLife · doi:10.7554/elife.110324.2
A phosphorylation switch governs KIF11’s mechanical output during mitosis
Šemić, A., Reddy, B. J. N., Muretta, J. M., Vandal, S. E., Thompson, A. F., Fonseca, C. L., Rosenfeld, S. S., Gross, S. P., & Stumpff, J. K. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2602415123
Iranmehr, Z., Sharahi, H. Y., Eslahchi, C., Ghaemi, F., Wadji, M. B., Miri, S. R., & Ebrahimi, M. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12888-3
Burday, N., Guerrero-Barberà, G., Jayo, A., del Pino, M. M. S., Zapater, E. O., & Costell, M. (2026) · Matrix Biology · doi:10.1016/j.matbio.2026.102067
BindingDB Entry 50018748: Recent researches for dual Aurora target inhibitors in antitumor field.
BindingDB (2024) · UC San Diego · doi:10.7270/q2tt4w5v
BindingDB (2013) · UC San Diego · doi:10.7270/q2319wzm
BindingDB Entry 50030666: Structural basis for the inhibitor recognition of human Lyn kinase domain.
BindingDB (2010) · UC San Diego · doi:10.7270/q2tt4r1d
BindingDB Entry 50028533: Structure-based virtual screening of Src kinase inhibitors.
BindingDB (2010) · UC San Diego · doi:10.7270/q2v9880t
BindingDB (2019) · UC San Diego · doi:10.7270/q2s184rn
BindingDB (2010) · UC San Diego · doi:10.7270/q2h41r78
Pharmacologic Factors: Anaesthetic Agents that May Influence Cancer Outcomes: Local Anaesthetics
Borgeat, A., Schick, C., & Votta‐Velis, G. (2015) · Current anesthesiology reports · doi:10.1007/s40140-015-0112-y
The role of cell cycle control mechanisms in regulated and sustained cell proliferation
Hultman, T. (2013) · Epsilon Archive for Student Projects (University of Southampton)
Seemann, H. (2013) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4083
Development of novel therapies for colorectal carcinoma using dietary indoles
Brookes, A. (2014) · Leicester Research Archive (University of Leicester)
Mitochondrion: A Novel Center for Cancer Cell Signaling
Miriyala, S., Holley, A. K., & Clair, D. K. S. (2014) · Springer eBooks · doi:10.1007/978-94-017-8984-4_1
Metadata
- Authors
- Summy, J. M., & Gallick, G. E.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Gallick, Gary E.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2003-12
- Volume
- 22
- Issue
- 4
- Pages
- 337-358
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W1589166971
- Cited by
- 827
- References
- 171
- Citations by year
- 2026: 15 · 2025: 15 · 2024: 17 · 2023: 17 · 2022: 26 · 2021: 27 · 2020: 26 · 2019: 35 · 2018: 32 · 2017: 28 · 2016: 32 · 2015: 37 · 2014: 64 · 2013: 55 · 2012: 49
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Cancer and Metastasis Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ca065527-07)
- National Cancer Institute (U54CA090810, 2 R01 CA65527)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- Src family kinases, Src kinase, non-receptor tyrosine kinase, tumor progression, metastasis, constitutive kinase activation, v-Src, malignant transformation, cell migration and invasion, angiogenesis, apoptosis resistance, cancer therapeutics, colorectal cancer, breast cancer, melanoma, lung cancer
- MeSH terms
- Enzyme Activation, Humans, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Signal Transduction, Disease Progression, src-Family Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review